Australia Stock Exchange release from NEUROSCIENTIFIC : 2021 Annual Report and Appendix 4E
Australia Stock Exchange release from NEUROSCIENTIFIC NSB.AX : 2021 Annual Report and Appendix 4E
Recent news on Neuroscientific Biopharmaceuticals
See all newsBrief: Neuroscientific Biopharmaceuticals Appoints Chris Knee As CFO
Brief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results
Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO